| 1TW6: reference: Engineering ML-IAP to produce an extraordinarily potent caspase-9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP., Vucic D, Franklin MC, Wallweber HJ, Das K, Eckelman BP, Shin H, Elliott LO, Kadkhodayan S, Deshayes K, Salvesen G, Fairbrother WJ, Biochem J 2004 Oct 15;. PMID: 15485396 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).